Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT03545451
Eligibility Criteria:
Inclusion Criteria:
Common to the 3 populations concerned:
* patients or subjects of both sexes;
* age: 18-70 years;
* ability to give consent in writing;
* Health Insurance.
a) SLA:
* patients with amyotrophic lateral sclerosis (defined according to the El Escorial criteria: possible, probable or definite), at the time of diagnosis;
* Percentage of forced vital capacity (FVC) ≥ 65% of the predicted value for age, gender and size.
b) Patients after a shoulder trauma: patients with scheduled shoulder surgery. c) Healthy subjects.
Exclusion Criteria:
* Dementia (MMSE score \<24/30)
* Pregnancy or patient not having effective contraception.
* Other neurological, psychiatric or orthopedic disease leading to a motor handicap or an inability to correctly realize the experimental paradigm: interfering with the evaluation of the movements of the upper limb, incapacity to realize the mental imagery of the movement.
* Visual impairment resulting in an inability to properly view the computer screen.
* History of epilepsy or active epilepsy.
* Contraindication to MRI: cardiac or neuronal simulator, ferromagnetic surgical clips, implants and metal objects, intraocular foreign bodies, claustrophobia
* Persons under guardianship, trusteeship or any other administrative or judicial measure of deprivation of rights and liberty
* Subject in the exclusion period of another interventional research or participating in any other interventional research or therapeutic trial
* Presence of another severe progressive pathology
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03545451
Study Brief:
Protocol Section:
NCT03545451